JANX icon

Janux Therapeutics
JANX

Overview Fund Activity

215 hedge funds and large institutions have $3.43B invested in Janux Therapeutics in 2024 Q4 according to their latest regulatory filings, with 77 funds opening new positions, 80 increasing their positions, 43 reducing their positions, and 21 closing their positions.

Holders
215
Holders Change
+55
Holders Change %
+34.38%
% of All Funds
2.86%
Holding in Top 10
10
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+233.33%
% of All Funds
0.13%
New
77
Increased
80
Reduced
43
Closed
21
Calls
$37.7M
Puts
$19.7M
Net Calls
+$18M
Net Calls Change
+$43.7M

Top Buyers

1
RCM
1
RA Capital Management
Massachusetts
$555M
2
PBA
2
Paradigm Biocapital Advisors
New York
$188M
3
CAM
3
Cormorant Asset Management
Massachusetts
$112M
4
Janus Henderson Group
4
Janus Henderson Group
United Kingdom
$191M
5
Holocene Advisors
5
Holocene Advisors
New York
$54.3M

Top Sellers

1
O
1
OrbiMed
New York
$40.6M
2
VPC
2
Vestal Point Capital
New York
$0
3
CS
3
Candriam SCA
Luxembourg
$0
4
Hudson Bay Capital Management
4
Hudson Bay Capital Management
Connecticut
$1.61M
5
State Street
5
State Street
Massachusetts
$67.9M
Name Market Value Shares Shares
Change 		Shares
Change %
NNPTE
26
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne
Poland
$23M 429,392 -42,344 -9%
Pictet Asset Management
27
Pictet Asset Management
Switzerland
$20.6M 384,797 +384,797 New
FTM
28
First Turn Management
California
$20.5M 383,602 +383,602 New
Goldman Sachs
29
Goldman Sachs
New York
$20.4M 380,347 +64,612 +20%
Alyeska Investment Group
30
Alyeska Investment Group
Illinois
$18.5M 344,916 +141,732 +70%
RAM
31
Readystate Asset Management
Illinois
$18.2M 339,639 +307,304 +950%
PM
32
Prosight Management
Texas
$17.7M 329,768 +124,768 +61%
FLAM
33
First Light Asset Management
Minnesota
$16.8M 313,782 +313,782 New
Northern Trust
34
Northern Trust
Illinois
$16.5M 308,800 +42,302 +16%
Invesco
35
Invesco
Georgia
$15.2M 284,662 +274,724 +2,764%
Charles Schwab
36
Charles Schwab
California
$14.6M 273,135 +38,944 +17%
Barclays
37
Barclays
United Kingdom
$14.1M 263,970 +89,909 +52%
SI
38
Sofinnova Investments
California
$13.6M 253,262 +88,492 +54%
Victory Capital Management
39
Victory Capital Management
Texas
$13M 242,409 +212,664 +715%
TLP
40
Tri Locum Partners
New York
$12.7M 236,407 +236,407 New
MB
41
MPM BioImpact
Massachusetts
$12.3M 230,000 +58,895 +34%
Qube Research & Technologies (QRT)
42
Qube Research & Technologies (QRT)
United Kingdom
$12.3M 229,390 +229,390 New
UBS Group
43
UBS Group
Switzerland
$12.1M 225,090 +170,896 +315%
Morgan Stanley
44
Morgan Stanley
New York
$11.7M 217,831 +77,367 +55%
RSCM
45
Rock Springs Capital Management
Maryland
$10.9M 204,466 +204,466 New
Skandinaviska Enskilda Banken (SEB)
46
Skandinaviska Enskilda Banken (SEB)
Sweden
$10.8M 205,167 +170,520 +492%
IHAM
47
Integral Health Asset Management
New York
$10.7M 200,000 +200,000 New
JPMorgan Chase & Co
48
JPMorgan Chase & Co
New York
$10.3M 191,603 +173,211 +942%
RCM
49
Ratan Capital Management
Florida
$9.6M 179,307 +150,507 +523%
SL
50
Siren LLC
Connecticut
$9.37M 175,000 +175,000 New
1
2
3 4 5